Your browser doesn't support javascript.
loading
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami, Azadeh; Eyjolfsdottir, Helga; Vijayaraghavan, Swetha; Lind, Göran; Almqvist, Per; Kadir, Ahmadul; Linderoth, Bengt; Andreasen, Niels; Blennow, Kaj; Wall, Anders; Westman, Eric; Ferreira, Daniel; Kristoffersen Wiberg, Maria; Wahlund, Lars-Olof; Seiger, Åke; Nordberg, Agneta; Wahlberg, Lars; Darreh-Shori, Taher; Eriksdotter, Maria.
Afiliação
  • Karami A; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden.
  • Eyjolfsdottir H; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden.
  • Vijayaraghavan S; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Lind G; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
  • Almqvist P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
  • Kadir A; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Linderoth B; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
  • Andreasen N; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden.
  • Blennow K; Department of Clinical Neuroscience, Clinical Neurochemistry Laboratory, University of Göteborg, Göteborg, Sweden.
  • Wall A; Nuclear medicine and PET, Department of Surgical Sciences, Uppsala University, Sweden.
  • Westman E; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden.
  • Ferreira D; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Kristoffersen Wiberg M; Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.
  • Wahlund LO; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden.
  • Seiger Å; Stockholms sjukhem, Stockholm, Sweden.
  • Nordberg A; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden.
  • Wahlberg L; NsGene Inc, Providence, RI, USA.
  • Darreh-Shori T; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden. Electronic address: Taher.Darreh-Shori@ki.se.
  • Eriksdotter M; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden. Electronic address: maria.eriksdotter@ki.se.
Alzheimers Dement ; 11(11): 1316-28, 2015 Nov.
Article em En | MEDLINE | ID: mdl-25676388

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilcolinesterase / Colina O-Acetiltransferase / Fator de Crescimento Neural / Doença de Alzheimer Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilcolinesterase / Colina O-Acetiltransferase / Fator de Crescimento Neural / Doença de Alzheimer Idioma: En Ano de publicação: 2015 Tipo de documento: Article